Skip to main content
Premium Trial:

Request an Annual Quote

Digital Gene Technologies Closes $22 M Placement

Premium

L

A JOLLA, Calif.--Privately held Digital Gene Technologies said it would use $22 million that it secured in a recent private placement to accelerate deployment of its automated assay technology and to advance its bioinformatics development.

Digital Gene’s Total Gene Expression Analysis product is a patented method of identifying and determining the concentration of genes active in a sample cell or tissue.

The company said it self-managed the oversubscribed third round of financing, which brought in capital from current shareholders and new investors. Since its inception in 1995 Digital Gene has raised $34 million.

Filed under

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.